Observational analysis identifies systemic inflammatory response index as a significant prognostic factor for survival in pancreatic cancer patients, suggesting its value in clinical evaluations.
Aims Pancreatic cancer has a very poor prognosis and is a leading cause of cancer-related deaths. Our aim is to investigate the presence of novel prognostic markers in pancreatic cancer that are easy to calculate, inexpensive, non-invasive, and do not cause a loss of time.
No takes yet. Share an insight, caveat, or question.
Yolaçan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: